These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8095331)

  • 41. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Reflux esophagitis].
    Mitsunaga A; Matsumoto R; Hoshino Y; Nakamura S; Murata Y; Oi I; Hayashi N
    Nihon Rinsho; 2002 Aug; 60(8):1559-65. PubMed ID: 12187751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-ulcer drugs. Indications in adults. French Agency of the Safety of Health Products].
    Presse Med; 2000 Jan; 29(2):86-94. PubMed ID: 10682037
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers].
    Imaizumi H; Koizumi W; Nakai H; Tanabe S; Ohida M; Saigenji K
    Nihon Rinsho; 1999 Jan; 57(1):167-72. PubMed ID: 10036957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
    Labenz J; Tillenburg B; Peitz U; Köhl H; Becker T; Stolte M; Börsch G
    Dtsch Med Wochenschr; 1996 Jan; 121(1-2):3-7; discussion 7-8. PubMed ID: 8565802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
    Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [H2-blocker refractory ulcers: what can be done?].
    Dammann HG
    Z Gastroenterol; 1992 Apr; 30(4):268-71. PubMed ID: 1351328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers.
    Meijer JL; Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of acid secretion in peptic ulcer disease.
    Feldman M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-6. PubMed ID: 7673607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Recent studies on therapy of peptic ulcers].
    Asaka M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1750-4. PubMed ID: 10581758
    [No Abstract]   [Full Text] [Related]  

  • 54. Ulcer disease of the upper gastrointestinal tract.
    Meeroff JC
    Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
    [No Abstract]   [Full Text] [Related]  

  • 55. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
    Park SM; Park J; Chang SK; Yoo BC; Kim HJ
    Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan.
    Habu Y; Mizuno S; Hirano S; Kiyota K; Inokuchi H; Kimoto K; Nakajima M; Kawai K
    Digestion; 1998; 59(4):321-5. PubMed ID: 9693202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathogenesis and therapy of gastric and duodenal ulcer disease.
    Shiotani A; Graham DY
    Med Clin North Am; 2002 Nov; 86(6):1447-66, viii. PubMed ID: 12510460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
    Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
    Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.